Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Iscience|December 1, 2025
Fosl1 is a transcriptional effector of BRAF V600E-driven intestinal tumorigenesisZakia Alam, Rebecca Nightingale, Analia Lesmana, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Brush border myosin Ia has tumor suppressor activity in the intestineRocco Mazzolini, Higinio Dopeso, Silvia Mateo-Lozano, et al.
Nature Communications|November 22, 2014
RHOA inactivation enhances Wnt signalling and promotes colorectal cancerPaulo Rodrigues, Irati Macaya, Sarah Bazzocco, et al.
Cancer Research|June 24, 2010
Genomic and biological characterization of exon 4 KRAS mutations in human cancerManickam Janakiraman, Efsevia Vakiani, Zhaoshi Zeng, et al.
Iscience|November 16, 2019
Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug TargetsDavid K Lau, Dmitri Mouradov, Wiphawan Wasenang, et al.
International Journal of Cancer|September 25, 2012
Brush border myosin Ia inactivation in gastric but not endometrial tumorsRocco Mazzolini, Paulo Rodrigues, Sarah Bazzocco, et al.
Nature Communications|November 24, 2019
Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesityMercedes Dávalos-Salas, Magdalene K Montgomery, Camilla M Reehorst, et al.
Molecular Cancer Therapeutics|November 7, 2022
Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell DeathLaura J Jenkins, Ian Y Luk, W Douglas Fairlie, et al.
Pageof 12